Prostaglandin E2 synthesis in human epidermis and its inhibition by unsaturated fatty acids.
D000818:Animals; D001095:Arachidonic Acids / Q000378:metabolism; D001241:Aspirin / Q000494:pharmacology; D002250:Carbon Radioisotopes; D003677:Deficiency Diseases / Q000188:drug therapy / Q000378:metabolism; D005228:Fatty Acids, Essential; D005231:Fatty Acids, Unsaturated / Q000494:pharmacology*; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology; D008042:Linolenic Acids / Q000494:pharmacology; D008861:Microsomes / Q000187:drug effects / Q000378:metabolism; D011453:Prostaglandins / Q000096:biosynthesis* / Q000627:therapeutic use; D051381:Rats; D012867:Skin / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D012871:Skin Diseases / Q000188:drug therapy; D013256:Steroids / Q000494:pharmacology; D013329:Structure-Activity Relationship; D013347:Subcellular Fractions / Q000378:metabolism
D001095:Arachidonic Acids; D002250:Carbon Radioisotopes; D005228:Fatty Acids, Essential; D005231:Fatty Acids, Unsaturated; D008042:Linolenic Acids; D011453:Prostaglandins; D013256:Steroids; D001241:Aspirin; D007213:Indomethacin